Long-term tracking of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy use

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The RSSearch Registry is an international database that collects data on the use of Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) for treating various tumors and conditions. It aims to track treatment practices and outcomes over time, allowing healthcare providers to analyze the effectiveness of these therapies. Participants can record patient characteristics, treatment plans, and outcomes, facilitating quality improvement and collaboration among treatment centers. The registry also includes both prospective enrollment and retrospective data to capture comprehensive treatment outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
* Willingness to sign an Informed Consent Document or verbally agree to participation

Exclusion Criteria:

* There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

Where it's running

• Sylvester Comprehensive Cancer Center, University of Miami
  Miami, Florida, United States Recruiting
• Henry Ford Health System
  Detroit, Michigan, United States Recruiting
• Penrose Cancer Center
  Colorado Springs, Colorado, United States Enrolling by invitation
• Southeast Georgia Health System
  Brunswick, Georgia, United States Enrolling by invitation
• AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute
  Egg Harbor, New Jersey, United States Enrolling by invitation
• Riverview Medical Center
  Red Bank, New Jersey, United States Enrolling by invitation

Study contacts

• Study coordinator: Jan Jenkins, RN
• Email: jjenkins@therss.org

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HR20013 for preventing nausea and vomiting in cancer patients receiving chemotherapy

  This real-world study tests whether HR20013 helps prevent nausea and vomiting in adults with cancer who are getting chemotherapy.

  Recruiting Sun Yat-sen University · Guangzhou, Guangdong · NCT07874308

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• Ready for Safe Cancer Treatment (RESET): A comprehensive perioperative program for surgical patients

  The RESET program tests a structured, multidisciplinary perioperative plan to improve safety and recovery for adults having planned cancer surgery and older adults having planned non cancer-related surgery.

  Recruiting at 2 sites Regional Specialist Hospital in Wroclaw · Wroclaw, Lower Silesian Voivodeship and 1 other locations · NCT07727876

• How environment and biology together predict health, aging, and death

  Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.

  Recruiting Longevity Metrics, Inc. · Boulder, Colorado · NCT07646782

• Metastatic liver cancer patient registry from multiple Chinese centers

  This is a registry that collects real-world data on adults with liver metastases to understand patterns and prognosis and to support future research.

  Recruiting at 2 sites Anhui Provincial Hospital · Bengbu, Anhui and 2 other locations · NCT07602504

• RP-008 with daily varenicline for trigeminal neuralgia

  A new treatment approach tests RP-008 together with varenicline to see if it is safe, tolerable, and offers pain relief for adults with trigeminal neuralgia.

  Recruiting Phase 1/2 Kriya Therapeutics, Inc. · Sherbrooke · NCT07596485

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.